What does this decision mean?
Tests by the National Medicines Institute showed failure to meet specification requirements for subvisible particulate contamination (negative result for particles ≥10 μm) and non-compliance of the reconstituted solution appearance with the registration dossier. Potential effects: complications after intravenous administration, local reactions, risk to treatment safety.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Related
27.05.2026
25.05.2026
22.05.2026
22.05.2026
22.05.2026